Changes in the metabolism of sphingolipids after subarachnoid hemorrhage

Journal of Neuroscience Research

Volumn 93, Issue 5, 2015, Pages 796-805

  Testai, Fernando D ^a   Xu, Hao Liang ^a   Kilkus, John ^b   Suryadevara, Vidyani ^a   Gorshkova, Irina ^a   Berdyshev, Evgeny ^a   Pelligrino, Dale A ^a   Dawson, Glyn ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cerebrovascular disorders; Sphingolipids; Subarachnoid hemorrhage

Indexed keywords

CERAMIDE; CERAMIDE GLUCOSYLTRANSFERASE; DIHYDROCERAMIDE; LYASE; SPHINGOLIPID; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELINASE SYNTHASE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE LYASE; SYNTHETASE; UNCLASSIFIED DRUG; ALPHA LEVO FUCOSIDASE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN HOMOGENATE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID HOMEOSTASIS; LIPID METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBARACHNOID HEMORRHAGE; ADOLESCENT; ANIMAL; COMPLICATION; LASER DOPPLER FLOWMETRY; MASS SPECTROMETRY; METABOLIC DISEASES; METABOLISM; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; ALPHA-L-FUCOSIDASE; ANIMALS; CERAMIDES; FEMALE; HUMANS; LASER-DOPPLER FLOWMETRY; MALE; MASS SPECTROMETRY; METABOLIC DISEASES; MIDDLE AGED; RATS; SPHINGOLIPIDS; SUBARACHNOID HEMORRHAGE; YOUNG ADULT;

EID: 84925587638     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23542     Document Type: Article

References (59)

1. Altay O, Suzuki H, Hasegawa Y, Ostrowski RP, Tang J, Zhang JH. 2014. Isoflurane on brain inflammation. Neurobiol Dis 62:365-371.
2. Altura BM, Gebrewold A, Zheng T, Altura BT. 2002. Sphingomyelinase and ceramide analogs induce vasoconstriction and leukocyte-endothelial interactions in cerebral venules in the intact rat brain: Insight into mechanisms and possible relation to brain injury and stroke. Brain Res Bull 58:271-278.
3. Bedia C, Camacho L, Casas J, Abad JL, Delgado A, Van Veldhoven PP, Fabrias G. 2009. Synthesis of a fluorogenic analogue of sphingosine-1-phosphate and its use to determine sphingosine-1-phosphate lyase activity. Chembiochem 10:820-822.
4. Berdyshev EV, Gorshkova IA, Garcia JG, Natarajan V, Hubbard WC. 2005. Quantitative analysis of sphingoid base-1-phosphates as bisacetylated derivatives by liquid chromatography-tandem mass spectrometry. Anal Biochem 339:129-136.
5. Bligh EG, Dyer WJ. 1959. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-917.
6. Breen P, Joseph N, Thompson K, Kraveka JM, Gudz TI, Li L, Rahmaniyan M, Bielawski J, Pierce JS, VAN Buren E, Bhatti G, Separovic D. 2013. Dihydroceramide desaturase knockdown impacts sphingolipids and apoptosis after photodamage in human head and neck squamous carcinoma cells. Anticancer Res 33:77-84.
7. Brunkhorst R, Kanaan N, Koch A, Ferreiros N, Mirceska A, Zeiner P, Mittelbronn M, Derouiche A, Steinmetz H, Foerch C, Pfeilschifter J, Pfeilschifter W. 2013. FTY720 treatment in the convalescence period improves functional recovery and reduces reactive astrogliosis in photothrombotic stroke. PLoS One 8:e70124.
8. Crowley RW, Medel R, Dumont AS, Ilodigwe D, Kassell NF, Mayer SA, Ruefenacht D, Schmiedek P, Weidauer S, Pasqualin A, Macdonald RL. 2011. Angiographic vasospasm is strongly correlated with cerebral infarction after subarachnoid hemorrhage. Stroke 42:919-923.
9. Dmitrieva VG, Torshina EV, Yuzhakov VV, Povarova OV, Skvortsova VI, Limborska SA, Dergunova LV. 2008. Expression of sphingomyelin synthase 1 gene in rat brain focal ischemia. Brain Res 1188:222-227.
10. Farooqui AA, Horrocks LA, Farooqui T. 2007. Interactions between neural membrane glycerophospholipid and sphingolipid mediators: a recipe for neural cell survival or suicide. J Neurosci Res 85:1834-1850.
11. Fu Y, Hao J, Zhang N, Ren L, Sun N, Li YJ, Yan Y, Huang D, Yu C, Shi FD. 2014. Fingolimod for the treatment of intracerebral hemorrhage: a 2-arm proof-of-concept study. JAMA Neurol (in press).
12. Fyrst H, Saba JD. 2010. An update on sphingosine-1-phosphate and other sphingolipid mediators. Nat Chem Biol 6:489-497.
13. Gupta V, Bhinge KN, Hosain SB, Xiong K, Gu X, Shi R, Ho MY, Khoo KH, Li SC, Li YT, Ambudkar SV, Jazwinski SM, Liu YY. 2012. Ceramide glycosylation by glucosylceramide synthase selectively maintains the properties of breast cancer stem cells. J Biol Chem 287:37195-37205.
14. Hannun YA, Obeid LM. 2008. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 9:139-150.
15. Hasegawa Y, Suzuki H, Sozen T, Rolland W, Zhang JH. 2010. Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats. Stroke 41:368-374.
16. Haynes TA, Filippov V, Filippova M, Yang J, Zhang K, Duerksen-Hughes PJ. 2012. DNA damage induces down-regulation of UDP-glucose ceramide glucosyltransferase, increases ceramide levels and triggers apoptosis in p53-deficient cancer cells. Biochim Biophys Acta 1821:943-953.
17. Herr I, Martin-Villalba A, Kurz E, Roncaioli P, Schenkel J, Cifone MG, Debatin KM. 1999. FK506 prevents stroke-induced generation of ceramide and apoptosis signaling. Brain Res 826:210-219.
18. Hisaki H, Okazaki T, Kubota M, Nakane M, Fujimaki T, Nakayama H, Nakagomi T, Tamura A, Masuda H. 2008. L-PDMP improves glucosylceramide synthesis and behavior in rats with focal ischemia. Neurol Res 30:979-984.
19. Kawabori M, Kacimi R, Karliner JS, Yenari MA. 2013. Sphingolipids in cardiovascular and cerebrovascular systems: Pathological implications and potential therapeutic targets. World J Cardiol 5:75-86.
20. Kilkus J, Goswami R, Testai FD, Dawson G. 2003. Ceramide in rafts (detergent-insoluble fraction) mediates cell death in neurotumor cell lines. J Neurosci Res 72:65-75.
21. Kilkus JP, Goswami R, Dawson SA, Testai FD, Berdyshev EV, Han X, Dawson G. 2008. Differential regulation of sphingomyelin synthesis and catabolism in oligodendrocytes and neurons. J Neurochem 106:1745-1757.
22. Kwak DH, Kim SM, Lee DH, Kim JS, Kim SM, Lee SU, Jung KY, Seo BB, Choo YK. 2005. Differential expression patterns of gangliosides in the ischemic cerebral cortex produced by middle cerebral artery occlusion. Mol Cells 20:354-360.
23. Lev S. 2010. Nonvesicular lipid transport by lipid-transfer proteins and beyond. Nat Rev Mol Cell Biol 11:739-750.
24. Liu JR, Ding MP, Wei EQ, Luo JH, Song Y, Huang JZ, Ge QF, Hu H, Zhu LJ. 2005. GM1 stabilizes expression of NMDA receptor subunit 1 in the ischemic hemisphere of MCAo/reperfusion rat. J Zhejiang Univ Sci B 6:254-258.
25. Lopez-Montero I, Rodriguez N, Cribier S, Pohl A, Velez M, Devaux PF. 2005. Rapid transbilayer movement of ceramides in phospholipid vesicles and in human erythrocytes. J Biol Chem 280:25811-25819.
26. Macdonald RL, Pluta RM, Zhang JH. 2007. Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution. Nat Clin Pract Neurol 3:256-263.
27. Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, Vajkoczy P, Wanke I, Bach D, Frey A, Marr A, Roux S, Kassell N. 2011. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid hemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol 10:618-625.
28. Mielke MM, Haughey NJ, Bandaru VV, Weinberg DD, Darby E, Zaidi N, Pavlik V, Doody RS, Lyketsos CG. 2011. Plasma sphingomyelins are associated with cognitive progression in Alzheimer's disease. J Alzheimers Dis 27:259-269.
29. Mielke MM, Maetzler W, Haughey NJ, Bandaru VV, Savica R, Deuschle C, Gasser T, Hauser AK, Graber-Sultan S, Schleicher E, Berg D, Liepelt-Scarfone I. 2013. Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot study. PLoS One 8:e73094.
30. Novgorodov SA, Gudz TI. 2009. Ceramide and mitochondria in ischemia/reperfusion. J Cardiovasc Pharmacol 53:198-208.
31. Ohtani R, Tomimoto H, Kondo T, Wakita H, Akiguchi I, Shibasaki H, Okazaki T. 2004. Upregulation of ceramide and its regulating mechanism in a rat model of chronic cerebral ischemia. Brain Res 1023:31-40.
32. Pfeilschifter W, Czech-Zechmeister B, Sujak M, Mirceska A, Koch A, Rami A, Steinmetz H, Foerch C, Huwiler A, Pfeilschifter J. 2011. Activation of sphingosine kinase 2 is an endogenous protective mechanism in cerebral ischemia. Biochem Biophys Res Commun 413:212-217.
33. Pluta RM, Hansen-Schwartz J, Dreier J, Vajkoczy P, Macdonald RL, Nishizawa S, Kasuya H, Wellman G, Keller E, Zauner A, Dorsch N, Clark J, Ono S, Kiris T, Leroux P, Zhang JH. 2009. Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought. Neurol Res 31:151-158.
34. Pyne NJ, Pyne S. 2010. Sphingosine 1-phosphate and cancer. Nat Rev Cancer 10:489-503.
35. Qin J, Testai FD, Dawson S, Kilkus J, Dawson G. 2009. Oxidized phosphatidylcholine formation and action in oligodendrocytes. J Neurochem 110:1388-1399.
36. Qin J, Berdyshev E, Goya J, Natarajan V, Dawson G. 2010. Neurons and oligodendrocytes recycle sphingosine 1-phosphate to ceramide: significance for apoptosis and multiple sclerosis. J Biol Chem 285:14134-14143.
37. Rolland WB 2nd, Manaenko A, Lekic T, Hasegawa Y, Ostrowski R, Tang J, Zhang JH. 2011. FTY720 is neuroprotective and improves functional outcomes after intracerebral hemorrhage in mice. Acta Neurochir Suppl 111:213-217.
38. Sehba FA, Pluta RM, Macdonald RL. 2013. Brain injury after transient global cerebral ischemia and subarachnoid hemorrhage. Stroke Res Treat 2013:827154.
39. Sentelle RD, Senkal CE, Jiang W, Ponnusamy S, Gencer S, Selvam SP, Ramshesh VK, Peterson YK, Lemasters JJ, Szulc ZM, Bielawski J, Ogretmen B. 2012. Ceramide targets autophagosomes to mitochondria and induces lethal mitophagy. Nat Chem Biol 8:831-838.
40. Siddique MM, Li Y, Wang L, Ching J, Mal M, Ilkayeva O, Wu YJ, Bay BH, Summers SA. 2013. Ablation of dihydroceramide desaturase 1, a therapeutic target for the treatment of metabolic diseases, simultaneously stimulates anabolic and catabolic signaling. Mol Cell Biol 33:2353-2369.
41. Stiban J, Fistere D, Colombini M. 2006. Dihydroceramide hinders ceramide channel formation: Implications on apoptosis. Apoptosis 11:773-780.
42. Takahashi K, Ginis I, Nishioka R, Klimanis D, Barone FC, White RF, Chen Y, Hallenbeck JM. 2004. Glucosylceramide synthase activity and ceramide levels are modulated during cerebral ischemia after ischemic preconditioning. J Cereb Blood Flow Metab 24:623-627.
43. Testai FD, Landek MA, Dawson G. 2004a. Regulation of sphingomyelinases in cells of the oligodendrocyte lineage. J Neurosci Res 75:66-74.
44. Testai FD, Landek MA, Goswami R, Ahmed M, Dawson G. 2004b. Acid sphingomyelinase and inhibition by phosphate ion: role of inhibition by phosphatidyl-myo-inositol 3, 4, 5-triphosphate in oligodendrocyte cell signaling. J Neurochem 89:636-644.
45. Testai FD, Hillmann M, Amin-Hanjani S, Gorshkova I, Berdyshev E, Gorelick PB, Dawson G. 2012. Changes in the cerebrospinal fluid ceramide profile after subarachnoid hemorrhage. Stroke 43:2066-2070.
46. Testai FD, Kilkus JP, Berdyshev E, Gorshkova I, Natarajan V, Dawson G. 2014. Multiple sphingolipid abnormalities following cerebral microendothelial hypoxia. J Neurochem (in press).
47. Tian HP, Qiu TZ, Zhao J, Li LX, Guo J. 2009. Sphingomyelinase-induced ceramide production stimulate calcium-independent JNK and PP2A activation following cerebral ischemia. Brain Inj 23:1073-1080.
48. Tosaka M, Okajima F, Hashiba Y, Saito N, Nagano T, Watanabe T, Kimura T, Sasaki T. 2001. Sphingosine 1-phosphate contracts canine basilar arteries in vitro and in vivo: possible role in pathogenesis of cerebral vasospasm. Stroke 32:2913-2919.
49. Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, Schwille P, Brugger B, Simons M. 2008. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319:1244-1247.
50. Vaskovsky VE, Kostetsky EY, Vasendin IM. 1975. A universal reagent for phospholipid analysis. J Chromatogr 114:129-141.
51. Wacker BK, Perfater JL, Gidday JM. 2012. Hypoxic preconditioning induces stroke tolerance in mice via a cascading HIF, sphingosine kinase, and CCL2 signaling pathway. J Neurochem 123:954-962.
52. Wei Y, Yemisci M, Kim HH, Yung LM, Shin HK, Hwang SK, Guo S, Qin T, Alsharif N, Brinkmann V, Liao JK, Lo EH, Waeber C. 2011. Fingolimod provides long-term protection in rodent models of cerebral ischemia. Ann Neurol 69:119-129.
53. Whitehead SN, Chan KH, Gangaraju S, Slinn J, Li J, Hou ST. 2011. Imaging mass spectrometry detection of gangliosides species in the mouse brain following transient focal cerebral ischemia and long-term recovery. PLoS One 6:e20808.
54. Xiao-Yun X, Zhuo-Xiong C, Min-Xiang L, Xingxuan H, Schuchman EH, Feng L, Han-Song X, An-Hua L. 2009. Ceramide mediates inhibition of the AKT/eNOS signaling pathway by palmitate in human vascular endothelial cells. Med Sci Monit 15:BR254-61.
55. Yamagishi K, Mishima K, Ohgami Y, Iwasaki K, Jimbo M, Masuda H, Igarashi Y, Inokuchi J, Fujiwara M. 2003. A synthetic ceramide analog ameliorates spatial cognition deficit and stimulates biosynthesis of brain gangliosides in rats with cerebral ischemia. Eur J Pharmacol 462:53-60.
56. Yu J, Novgorodov SA, Chudakova D, Zhu H, Bielawska A, Bielawski J, Obeid LM, Kindy MS, Gudz TI. 2007. JNK3 signaling pathway activates ceramide synthase leading to mitochondrial dysfunction. J Biol Chem 282:25940-25949.
57. Yu ZF, Nikolova-Karakashian M, Zhou D, Cheng G, Schuchman EH, Mattson MP. 2000. Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis. J Mol Neurosci 15:85-97.
58. Yung LM, Wei Y, Qin T, Wang Y, Smith CD, Waeber C. 2012. Sphingosine kinase 2 mediates cerebral preconditioning and protects the mouse brain against ischemic injury. Stroke 43:199-204.
59. Zhang QJ, Holland WL, Wilson L, Tanner JM, Kearns D, Cahoon JM, Pettey D, Losee J, Duncan B, Gale D, Kowalski CA, Deeter N, Nichols A, Deesing M, Arrant C, Ruan T, Boehme C, McCamey DR, Rou J, Ambal K, Narra KK, Summers SA, Abel ED, Symons JD. 2012. Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complex. Diabetes 61:1848-1859.